A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma
Clinical trial NCT03593187 · COMPLETED
Trial details
- NCT number
- NCT03593187
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-15
- Primary completion
- 2020-07-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.